SMC bars access to Actelion’s Uptravi on NHS Scotland
admin 11th July 2017 Uncategorised 0Actelion says it is disappointed with a decision by Scottish cost regulators to refuse NHS funding for pulmonary arterial hypertension drug Uptravi.
More: SMC bars access to Actelion’s Uptravi on NHS Scotland
Source: News